HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

6SLN-lipo PGA

has antiviral activity; structure in first source

Also Known As:

Neu5Ac2-6Gal1-4GlcNAc1-eicosanoyl chain polyglutamic acid; Neu5Acalpha2-6Galbeta1-4GlcNAcbeta1-eicosanoyl chain poly-alpha-L-glutamic acid

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Hiramatsu, Hiroaki: 1 article (10/2015)
2.	Kanie, Osamu: 1 article (10/2015)
3.	Sriwilaijaroen, Nongluk: 1 article (10/2015)
4.	Suzuki, Katsuhiko: 1 article (10/2015)
5.	Suzuki, Yasuo: 1 article (10/2015)
6.	Takashita, Emi: 1 article (10/2015)

Related Diseases

1.

Human Influenza (Influenza)

10/01/2015 - "6SLN-lipo PGA is a new potential candidate drug for influenza control and is an attractive candidate for use in combination with an NAI drug for minimized toxicity, delayed development of resistance, prevention and treatment with the potential for eradication of human influenza."
10/01/2015 - "6SLN-lipo PGA specifically catches (coats) human influenza virus and synergizes neuraminidase-targeting drugs for human influenza therapeutic potential."

Related Drugs and Biologics

1.	Neuraminidase (Sialidase)